# ARFGEF1

## Overview
The ARFGEF1 gene encodes the ADP ribosylation factor guanine nucleotide exchange factor 1, a pivotal protein involved in cellular trafficking processes. This protein, also known as BIG1, functions as a guanine nucleotide exchange factor (GEF) for ADP-ribosylation factors (ARFs), which are small GTP-binding proteins that regulate membrane dynamics and transport. ARFGEF1 is primarily localized in the Golgi apparatus and endosomal compartments, where it plays a critical role in maintaining Golgi structure and function, as well as facilitating vesicle formation and trafficking. As a member of the BIG/GBF1 family, ARFGEF1 is essential for processes such as glycosylation, neurite development, and axon elongation, which are vital for proper neuronal function (Thomas2021Haploinsufficiency; Xu2022Expanding). The protein's interactions with GABAA receptors and its involvement in signaling pathways further underscore its significance in cellular and neurological processes (Thomas2021Haploinsufficiency; Matsuyama2015MicroRNA‐27b).

## Structure
The ARFGEF1 protein, also known as ADP ribosylation factor guanine nucleotide exchange factor 1, is a 200-kDa protein involved in guanine nucleotide exchange on ADP ribosylation factors (ARFs), which are small GTP-binding proteins (Thomas2021Haploinsufficiency; Xu2022Expanding). A key structural feature of ARFGEF1 is the Sec7 domain, which is crucial for its guanine nucleotide exchange activity and is inhibited by brefeldin A (Xu2022Expanding). The Asp798 residue within the Sec7 domain is highly conserved across species, indicating its importance for the protein's function (Thomas2021Haploinsufficiency).

ARFGEF1 is part of the BIG/GBF1 family, which includes other guanine nucleotide exchange factors like ARFGEF2 and ARFGEF3 (Xu2022Expanding). The protein is involved in maintaining Golgi integrity and is essential for processes such as glycosylation and neurite development (Xu2022Expanding). The protein may undergo post-translational modifications, such as phosphorylation, which could regulate its activity (Miyamoto2018BIG1Arfgef1). However, specific details on the primary, secondary, tertiary, or quaternary structures of ARFGEF1 are not provided in the available context.

## Function
The ARFGEF1 gene encodes the ADP ribosylation factor guanine nucleotide exchange factor 1, also known as BIG1, which is crucial for cellular trafficking processes. This protein is involved in the exchange of GDP for GTP on ADP-ribosylation factors (ARFs), small GTPases that regulate membrane dynamics and transport. ARFGEF1 is primarily active in the Golgi apparatus and endosomal compartments, where it plays a significant role in maintaining the structure and function of the Golgi apparatus (Thomas2021Haploinsufficiency; Xu2022Expanding).

ARFGEF1 is essential for vesicle formation, a process critical for organelle biogenesis, cellular signaling, and membrane dynamics. It facilitates the trafficking of proteins and lipids between the Golgi apparatus and the plasma membrane, influencing processes like endocytosis and exocytosis (Thomas2021Haploinsufficiency). The protein is also involved in axon elongation, neurite development, and the polarization process, which are vital for proper neuronal function (Thomas2021Haploinsufficiency).

In addition to its role in cellular trafficking, ARFGEF1 interacts with GABAA receptors, and its depletion can lead to a decrease in these receptors at the neuronal surface, potentially impairing neuronal inhibition and increasing susceptibility to seizures (Thomas2021Haploinsufficiency).

## Clinical Significance
Mutations in the ARFGEF1 gene are associated with a range of neurodevelopmental disorders, including developmental delay, intellectual disability, and epilepsy, all of which exhibit variable expressivity. These conditions are often linked to haploinsufficiency of the ARFGEF1 gene, which affects cellular trafficking processes crucial for normal brain function (Thomas2021Haploinsufficiency). The gene has been identified as a candidate for rolandic epilepsy, familial febrile convulsions, and epileptic encephalopathy (Thomas2021Haploinsufficiency). In mouse models, ARFGEF1 haploinsufficiency leads to developmental delays and increased seizure susceptibility, supporting its role in these conditions (Teoh2020Arfgef1).

ARFGEF1 mutations can result in protein truncation or impaired function, contributing to neurodevelopmental disorders. These mutations include missense, splice site, and frameshift variants, some of which are de novo (Xu2022Expanding). The gene's role in maintaining endosomal balance and GABA A receptor recycling is crucial for neuronal inhibition, and disruptions in these processes may increase seizure susceptibility (Teoh2020Arfgef1).

Alterations in ARFGEF1 expression have also been implicated in cancer. In papillary thyroid cancer, miR-215 targets ARFGEF1, affecting the AKT/GSK-3β/Snail signaling pathway, which is important for cancer cell proliferation and metastasis (Han2019miR215).

## Interactions
ARFGEF1, also known as BIG1, is involved in several protein interactions that are crucial for its function in cellular processes. It acts as a guanine nucleotide exchange factor (GEF) for ARF1, facilitating the exchange of GDP for GTP, which is essential for vesicle trafficking and membrane dynamics. ARFGEF1 interacts with ARF1 at the trans-Golgi network, where it is recruited by the small G protein Arl1. This interaction is necessary for the Golgi localization of ARFGEF1 and its role in the Golgi Arf cascade, which involves a sequence of interactions from ARFRP1 to Arl1 and then to the TGN Arfs (Christis2012The).

In the context of Schwann cell myelination, ARFGEF1 is crucial for the initiation of myelination, interacting with Arf1 to regulate the AP1 transporting system. This interaction is important for the transport of myelin components, as evidenced by decreased myelin thickness in Schwann cell-specific knockout mice (Miyamoto2018BIG1Arfgef1). ARFGEF1 is also implicated in the activation of signaling pathways such as Akt and ERK1/2, which are important for cell survival and proliferation, although specific downstream targets remain unidentified (Matsuyama2015MicroRNA‐27b).


## References


[1. (Teoh2020Arfgef1) JiaJie Teoh, Narayan Subramanian, Maria Elena Pero, Francesca Bartolini, Ariadna Amador, Ayla Kanber, Damian Williams, Sabrina Petri, Mu Yang, Andrew S. Allen, Jules Beal, Sheryl R. Haut, and Wayne N. Frankel. Arfgef1 haploinsufficiency in mice alters neuronal endosome composition and decreases membrane surface postsynaptic gabaa receptors. Neurobiology of Disease, 134:104632, February 2020. URL: http://dx.doi.org/10.1016/j.nbd.2019.104632, doi:10.1016/j.nbd.2019.104632. This article has 8 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.nbd.2019.104632)

[2. (Miyamoto2018BIG1Arfgef1) Yuki Miyamoto, Tomohiro Torii, Kenji Tago, Akito Tanoue, Shou Takashima, and Junji Yamauchi. Big1/arfgef1 and arf1 regulate the initiation of myelination by schwann cells in mice. Science Advances, April 2018. URL: http://dx.doi.org/10.1126/sciadv.aar4471, doi:10.1126/sciadv.aar4471. This article has 40 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/sciadv.aar4471)

[3. (Matsuyama2015MicroRNA‐27b) Rei Matsuyama, Daisuke Okuzaki, Masato Okada, and Chitose Oneyama. Micro<scp>rna</scp>‐27b suppresses tumor progression by regulating <scp>arfgef</scp>1 and focal adhesion signaling. Cancer Science, 107(1):28–35, November 2015. URL: http://dx.doi.org/10.1111/cas.12834, doi:10.1111/cas.12834. This article has 35 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/cas.12834)

[4. (Xu2022Expanding) Lu Xu, Youfeng Zhou, Xiaoyan Ren, Chenlu Xu, Rongna Ren, Xuke Yan, Xuelian Li, Huimin Yang, Xuebin Xu, Xiaotong Guo, Guoxia Sheng, Yi Hua, Zhefeng Yuan, Shugang Wang, Weiyue Gu, Dan Sun, and Feng Gao. Expanding the phenotypic and genotypic spectrum of arfgef1-related neurodevelopmental disorder. Frontiers in Molecular Neuroscience, June 2022. URL: http://dx.doi.org/10.3389/fnmol.2022.862096, doi:10.3389/fnmol.2022.862096. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2022.862096)

[5. (Thomas2021Haploinsufficiency) Quentin Thomas, Thierry Gautier, Dana Marafi, Thomas Besnard, Marjolaine Willems, Sébastien Moutton, Bertand Isidor, Benjamin Cogné, Solène Conrad, Romano Tenconi, Maria Iascone, Arthur Sorlin, Alice Masurel, Tabib Dabir, Adam Jackson, Siddharth Banka, Julian Delanne, James R. Lupski, Nebal Waill Saadi, Fowzan S. Alkuraya, Fatema Al Zahrani, Pankaj B. Agrawal, Eleina England, Jill A. Madden, Jennifer E. Posey, Lydie Burglen, Diana Rodriguez, Martin Chevarin, Sylvie Nguyen, Frédéric Tran Mau-Them, Yannis Duffourd, Philippine Garret, Ange-Line Bruel, Patrick Callier, Nathalie Marle, Anne-Sophie Denomme-Pichon, Laurence Duplomb, Christophe Philippe, Christel Thauvin-Robinet, Jérôme Govin, Laurence Faivre, and Antonio Vitobello. Haploinsufficiency of arfgef1 is associated with developmental delay, intellectual disability, and epilepsy with variable expressivity. Genetics in Medicine, 23(10):1901–1911, October 2021. URL: http://dx.doi.org/10.1038/s41436-021-01218-6, doi:10.1038/s41436-021-01218-6. This article has 10 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41436-021-01218-6)

[6. (Han2019miR215) Jihua Han, Meiyin Zhang, Chunlei Nie, Jinliang Jia, Fengyue Wang, Jiawei Yu, Wen Bi, Bo Liu, Ruinan Sheng, Guoqing He, Lingyu Kong, Lingling Zheng, Rui Pang, Zhaoming Ding, Lili Chen, Qiang Guan, Shangha Pan, Xianzhi Meng, Jin Xu, Lianxin Liu, and Jiewu Zhang. Mir-215 suppresses papillary thyroid cancer proliferation, migration, and invasion through the akt/gsk-3β/snail signaling by targeting arfgef1. Cell Death &amp; Disease, February 2019. URL: http://dx.doi.org/10.1038/s41419-019-1444-1, doi:10.1038/s41419-019-1444-1. This article has 35 citations.](https://doi.org/10.1038/s41419-019-1444-1)

[7. (Christis2012The) Chantal Christis and Sean Munro. The small g protein arl1 directs the trans-golgi–specific targeting of the arf1 exchange factors big1 and big2. Journal of Cell Biology, 196(3):327–335, January 2012. URL: http://dx.doi.org/10.1083/jcb.201107115, doi:10.1083/jcb.201107115. This article has 61 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1083/jcb.201107115)